How I treat patients with hereditary antithrombin deficiency | Blood | American Society of Hematology
You do not currently have access to this content.
You do not currently have access to this content.
Key PointsInfrequent in CMML, AML-like mutations (CEBPA, FLT3, or NPM1) detect poor-prognosis CMML.
Abstract. The emergence of blastic plasmacytoid dendritic cell neoplasm (BPDCN) as its own distinct entity within the pantheon of hematologic malignancies
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
Key PointsCD37 is a surface receptor present on most AML blasts, which has unique internalization properties when compared with normal blood cells.Treatmen
Key PointsIn this retrospective analysis, siltuximab effectively treated CRS and ICANS with an objective response rate of 75% and 60%, respectively.Siltuxi
Key PointsBlast-specific ex vivo venetoclax sensitivity correlated strongly with treatment responses and predicted longer survival.VenEx trial showed that
Key PointsAmong 259 patients receiving CAR T cells for lymphoma, 26% had weight loss, defined as >5% reduction in body mass index in the preceding…
Key PointsThe native plasma FXIII complex structure reveals the intra- and intermolecular arrangement between/within the FXIII-A and -B subunits.The impact
Key PointsBCR repertoire analysis revealed frequent AID-initiated somatic hypermutation, isotype switching, and immunoglobulin gene fusion transcripts.The
A 48-year-old man with an unknown medical history presented with fatigue and weakness. His complete blood count revealed a white blood cell count of 221…